NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Henry Schein Medical Supports ASCA’s National Advocacy Day

Henry Schein Medical

Henry Schein Medical, the U.S. medical business of Henry Schein Inc., recently participated in the Ambulatory Surgery Center Association’s (ASCA) National Advocacy Day on Capitol Hill in Washington D.C. as part of the company’s commitment to amplify the value of ambulatory surgery centers (ASCs) and their role in helping to drive down heath care costs and deliver quality patient care.

In an effort to build relationships with the policymakers who make the decisions that directly impact the ambulatory surgery center community and its patients, Scott Jackson, vice president of surgical solutions at Henry Schein, along with 91 members of the ASC community representing 31 different states, met with representatives and their health staff to discuss the issues that are currently impacting ASCs and their patients. In particular, meetings addressed the Outpatient Surgery Quality and Access Act of 2023, which, if enacted, will ensure Medicare beneficiaries’ continued access to high-quality outpatient surgery.

“Ambulatory surgery centers have such a positive impact on the health care ecosystem, and being able to stand alongside ASCs to advocate on behalf of the surgery center community in the United States was an incredible experience,” said Jackson. “It is important that ASCs have their voices heard. By working together on the federal, state and local levels, we can create change, and help make an impact on legislation that will elevate and advance the ASC industry.”

According to ASCA, approximately 6,100 Medicare-certified ASCs provide care to America’s patients across the country. ASCA’s 2023 National Advocacy Day event was the first in-person event of its kind since 2019.

For more information, visit henryschein.com/asc.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X